Therapeutic sirna molecules for reducing vegfr1 expression...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 31/713 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2702039

The invention relates to nucleic acid molecule compositions for use in modulating the expression and activity of VEGF pathway genes and decreasing unwanted neovascularization, including tumor angiogenesis, by RNA interference and methods and compositions comprising the nucleic acid molecules.

La présente invention concerne des compositions de molécules d'acide nucléique destinées à être utilisées dans la modulation de l'expression et de l'activité des gènes de la voie VEGF et dans la diminution de la néovascularisation indésirable, incluant l'angiogenèse tumorale, par interférence ARN. L'invention concerne également des procédés et des compositions comprenant lesdites molécules d'acide nucléique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic sirna molecules for reducing vegfr1 expression... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic sirna molecules for reducing vegfr1 expression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic sirna molecules for reducing vegfr1 expression... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1490002

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.